Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cytokinetics, Incorporated (CYTK) vs Kymera Therapeutics, Inc. (KYMR)

Cytokinetics, Incorporated and Kymera Therapeutics, Inc. are both Biotechnology companies. Cytokinetics, Incorporated and Kymera Therapeutics, Inc. are of similar size ($9.7B and $9.0B). Kymera Therapeutics, Inc. grew revenue faster over the last twelve months: 134.8% against −21.1%. Kymera Therapeutics, Inc. has the higher net margin (−285.3% vs −1,321.1%) and the lower return on invested capital (−26.7% vs 0.00%). Across the 17 metrics below, Kymera Therapeutics, Inc. leads on 12 and Cytokinetics, Incorporated on 5.

Valuation

Metric CYTK KYMR Biotechnology median
P/E n/m n/m 7.88
P/S 126.21 105.17 11.47
P/B n/m 7.32 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 125.94 98.60 10.73
Earnings yield (11.17%) (2.88%) (28.84%)
Free cash flow yield (6.80%) (2.15%) (23.03%)

Profitability

Metric CYTK KYMR Biotechnology median
Gross margin 87.97% 100.00% 65.16%
Operating margin (1,046.12%) (333.50%) 0.00%
Net margin (1,321.12%) (285.33%) 0.00%
Free cash flow margin (858.16%) (226.62%) 0.00%
Return on equity 329.76% (24.15%) (57.72%)
Return on assets (56.76%) (21.58%) (49.22%)
Return on invested capital 0.00% (26.72%) 0.00%

Growth

Metric CYTK KYMR Biotechnology median
Revenue growth (TTM) (21.07%) 134.84% 5.64%
EPS growth (last fiscal year) (24.33%) (23.83%) —
Revenue growth, 5-year CAGR 9.54% 2.87% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYTK KYMR Biotechnology median
Debt to equity (6.61) 0.00 0.00
Current ratio 6.66 10.34 4.73
Net debt to EBITDA (0.46) 2.42 0.96

Dividend

Metric CYTK KYMR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CYTK KYMR Biotechnology median
Market cap 8.98b 9.69b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack